Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
13
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| McMinn Rachel | Chief Executive Officer, Director | 9 | $969.0K | $74.0K | 2026-09-22 |
| Cvijic Christine Mikail | President and CFO | 20 | $491.5K | $976.3K | 2026-07-07 |
| Shafer Christina | Chief Commercial Officer | 1 | $0 | $0 | 2026-05-05 |
| Jordan Julie | Chief Medical Officer | 6 | $0 | $18.1K | 2026-03-26 |
| Cobb Stuart | Chief Scientific Officer | 9 | $0 | $244.4K | 2026-03-13 |
| Woods Keith | Director | 4 | $0 | $0 | 2026-02-20 |
| Freedland Cory S. | Director | 4 | $0 | $0 | 2026-02-20 |
| Noonberg Sarah B. | Director | 4 | $0 | $0 | 2026-02-20 |
| PALEKAR ROHAN | Director | 4 | $0 | $0 | 2026-02-20 |
| BAFFI ROBERT | Director | 4 | $0 | $0 | 2026-02-20 |
| Woods Robert Keith | Director | 3 | $0 | $0 | 2025-06-12 |
| AKKARAJU SRINIVAS | 10% Owner | 4 | $1.26M | $0 | 2024-11-26 |
| BAKER BROS. ADVISORS LP | Director | 8 | $0 | $0 | 2023-12-18 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| McMinn Rachel | Chief Executive Officer, Dir | M Exercise deriv | 2026-09-22 | 2026-10-02 | 756 | — | $0 | 0 | SEC↗ |
| McMinn Rachel | Chief Executive Officer, Dir | M Exercise | 2026-09-22 | 2026-10-02 | 756 | $25.32 | $19.1K | 1,345,063 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | S Sale | 2026-07-07 | 2026-07-07 | 4,200 | $36.13 | $151.7K | 84,040 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | S Sale | 2026-07-06 | 2026-07-07 | 600 | $36.02 | $21.6K | 88,240 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | S Sale | 2026-07-02 | 2026-07-02 | 1,530 | $35.23 | $53.9K | 88,840 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | S Sale | 2026-07-02 | 2026-07-02 | 2,531 | $34.58 | $87.5K | 90,370 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | S Sale | 2026-07-01 | 2026-07-02 | 739 | $34.06 | $25.2K | 92,901 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | S Sale | 2026-05-06 | 2026-05-08 | 4,800 | $30.07 | $144.3K | 98,440 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | S Sale | 2026-05-06 | 2026-05-08 | 4,800 | $32.44 | $155.7K | 93,640 | SEC↗ |
| Shafer Christina | Chief Commercial Officer | A Award deriv | 2026-05-05 | 2026-05-07 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Jordan Julie | Chief Medical Officer | S Sale | 2026-03-26 | 2026-03-30 | 828 | $21.89 | $18.1K | 12,472 | SEC↗ |
| McMinn Rachel | Chief Executive Officer | S Sale | 2026-03-26 | 2026-03-30 | 3,352 | $22.07 | $74.0K | 1,344,307 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | S Sale | 2026-03-26 | 2026-03-30 | 2,558 | $21.62 | $55.3K | 103,240 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | S Sale | 2026-03-13 | 2026-03-17 | 2,387 | $20.42 | $48.7K | 107,456 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | S Sale | 2026-03-13 | 2026-03-17 | 1,395 | $21.25 | $29.6K | 106,061 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | S Sale | 2026-03-13 | 2026-03-17 | 263 | $22.02 | $5.8K | 105,798 | SEC↗ |
| Cobb Stuart | Chief Scientific Officer | S Sale | 2026-03-13 | 2026-03-17 | 148 | $22.08 | $3.3K | 30,497 | SEC↗ |
| Cobb Stuart | Chief Scientific Officer | S Sale | 2026-03-13 | 2026-03-17 | 3,991 | $20.41 | $81.5K | 33,303 | SEC↗ |
| Cobb Stuart | Chief Scientific Officer | S Sale | 2026-03-13 | 2026-03-17 | 2,658 | $21.34 | $56.7K | 30,645 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | S Sale | 2026-02-27 | 2026-03-03 | 4,800 | $25.11 | $120.5K | 109,843 | SEC↗ |
| Woods Keith | Director | A Award deriv | 2026-02-20 | 2026-02-24 | 12,050 | — | $0 | 12,050 | SEC↗ |
| Freedland Cory S. | Director | A Award deriv | 2026-02-20 | 2026-02-24 | 12,050 | — | $0 | 12,050 | SEC↗ |
| Noonberg Sarah B. | Director | A Award deriv | 2026-02-20 | 2026-02-24 | 12,050 | — | $0 | 12,050 | SEC↗ |
| BAFFI ROBERT | Director | A Award deriv | 2026-02-20 | 2026-02-24 | 12,050 | — | $0 | 12,050 | SEC↗ |
| PALEKAR ROHAN | Director | A Award deriv | 2026-02-20 | 2026-02-24 | 12,050 | — | $0 | 12,050 | SEC↗ |
| McMinn Rachel | Chief Executive Officer | A Award deriv | 2026-02-20 | 2026-02-24 | 155,100 | — | $0 | 155,100 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | A Award deriv | 2026-02-20 | 2026-02-24 | 131,900 | — | $0 | 131,900 | SEC↗ |
| Jordan Julie | Chief Medical Officer | A Award deriv | 2026-02-20 | 2026-02-24 | 29,600 | — | $0 | 29,600 | SEC↗ |
| McMinn Rachel | Chief Executive Officer | A Award | 2026-02-20 | 2026-02-24 | 25,900 | — | $0 | 1,347,659 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | A Award | 2026-02-20 | 2026-02-24 | 22,000 | — | $0 | 114,643 | SEC↗ |
| Jordan Julie | Chief Medical Officer | A Award | 2026-02-20 | 2026-02-24 | 4,900 | — | $0 | 13,300 | SEC↗ |
| Cobb Stuart | Chief Scientific Officer | A Award | 2026-02-20 | 2026-02-24 | 16,500 | — | $0 | 37,294 | SEC↗ |
| Woods Keith | Director | A Award deriv | 2025-06-12 | 2026-06-16 | 12,050 | — | $0 | 12,050 | SEC↗ |
| Noonberg Sarah B. | Director | A Award deriv | 2025-06-12 | 2025-06-13 | 12,050 | — | $0 | 12,050 | SEC↗ |
| Freedland Cory S. | Director | A Award deriv | 2025-06-12 | 2025-06-13 | 12,050 | — | $0 | 12,050 | SEC↗ |
| PALEKAR ROHAN | Director | A Award deriv | 2025-06-12 | 2025-06-13 | 12,050 | — | $0 | 12,050 | SEC↗ |
| Woods Robert Keith | Director | A Award deriv | 2025-06-12 | 2025-06-13 | 12,050 | — | $0 | 12,050 | SEC↗ |
| BAFFI ROBERT | Director | A Award deriv | 2025-06-12 | 2025-06-13 | 12,050 | — | $0 | 12,050 | SEC↗ |
| Cobb Stuart | Chief Scientific Officer | S Sale | 2025-05-14 | 2025-05-15 | 6,797 | $15.15 | $103.0K | 20,794 | SEC↗ |
| McMinn Rachel | Chief Executive Officer | A Award deriv | 2025-03-26 | 2025-03-28 | 143,500 | — | $0 | 143,500 | SEC↗ |
| Jordan Julie | Chief Medical Officer | A Award deriv | 2025-03-26 | 2025-03-28 | 50,300 | — | $0 | 50,300 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | A Award deriv | 2025-03-26 | 2025-03-28 | 122,000 | — | $0 | 122,000 | SEC↗ |
| Cobb Stuart | Chief Scientific Officer | A Award deriv | 2025-03-26 | 2025-03-28 | 42,900 | — | $0 | 42,900 | SEC↗ |
| McMinn Rachel | Chief Executive Officer | A Award | 2025-03-26 | 2025-03-28 | 23,900 | — | $0 | 1,274,259 | SEC↗ |
| Jordan Julie | Chief Medical Officer | A Award | 2025-03-26 | 2025-03-28 | 8,400 | — | $0 | 8,400 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | A Award | 2025-03-26 | 2025-03-28 | 20,300 | — | $0 | 92,643 | SEC↗ |
| Cobb Stuart | Chief Scientific Officer | A Award | 2025-03-26 | 2025-03-28 | 7,200 | — | $0 | 27,591 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | S Sale | 2025-03-13 | 2025-03-17 | 4,501 | $16.94 | $76.2K | 72,343 | SEC↗ |
| AKKARAJU SRINIVAS | 10% Owner | P Buy | 2024-11-26 | 2024-11-27 | 20,748 | $24.91 | $516.8K | 1,689,105 | SEC↗ |
| AKKARAJU SRINIVAS | 10% Owner | P Buy | 2024-11-26 | 2024-11-27 | 10,803 | $26.01 | $281.0K | 1,699,908 | SEC↗ |
| AKKARAJU SRINIVAS | 10% Owner | P Buy | 2024-11-26 | 2024-11-27 | 15,219 | $26.73 | $406.8K | 1,715,127 | SEC↗ |
| AKKARAJU SRINIVAS | 10% Owner | P Buy | 2024-11-26 | 2024-11-27 | 2,000 | $27.50 | $55.0K | 1,717,127 | SEC↗ |
| McMinn Rachel | Chief Executive Officer | P Buy | 2024-11-22 | 2024-11-25 | 47,500 | $20.40 | $969.0K | 1,297,859 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | P Buy | 2024-11-22 | 2024-11-25 | 24,000 | $20.48 | $491.5K | 76,844 | SEC↗ |
| Woods Keith | Director | A Award deriv | 2024-06-14 | 2026-06-16 | 7,700 | — | $0 | 7,700 | SEC↗ |
| Freedland Cory S. | Director | A Award deriv | 2024-06-14 | 2024-06-17 | 7,700 | — | $0 | 7,700 | SEC↗ |
| Noonberg Sarah B. | Director | A Award deriv | 2024-06-14 | 2024-06-17 | 7,700 | — | $0 | 7,700 | SEC↗ |
| BAFFI ROBERT | Director | A Award deriv | 2024-06-14 | 2024-06-17 | 7,700 | — | $0 | 7,700 | SEC↗ |
| PALEKAR ROHAN | Director | A Award deriv | 2024-06-14 | 2024-06-17 | 7,700 | — | $0 | 7,700 | SEC↗ |
| Woods Robert Keith | Director | A Award deriv | 2024-06-14 | 2024-06-17 | 7,700 | — | $0 | 7,700 | SEC↗ |
| Cobb Stuart | Chief Scientific Officer | A Award deriv | 2024-03-13 | 2024-03-14 | 34,450 | — | $0 | 34,450 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | A Award deriv | 2024-03-13 | 2024-03-14 | 53,900 | — | $0 | 53,900 | SEC↗ |
| McMinn Rachel | Chief Executive Officer | A Award deriv | 2024-03-13 | 2024-03-14 | 93,282 | — | $0 | 93,282 | SEC↗ |
| Cobb Stuart | Chief Scientific Officer | A Award | 2024-03-13 | 2024-03-14 | 20,391 | — | $0 | 20,391 | SEC↗ |
| Cvijic Christine Mikail | President and CFO | A Award | 2024-03-13 | 2024-03-14 | 31,903 | — | $0 | 52,844 | SEC↗ |
| Woods Keith | Director | A Award deriv | 2024-01-16 | 2026-06-16 | 15,400 | — | $0 | 15,400 | SEC↗ |
| Jordan Julie | Chief Medical Officer | A Award deriv | 2024-01-16 | 2024-01-18 | 75,000 | — | $0 | 75,000 | SEC↗ |
| BAFFI ROBERT | Director | A Award deriv | 2024-01-16 | 2024-01-18 | 15,400 | — | $0 | 15,400 | SEC↗ |
| Freedland Cory S. | Director | A Award deriv | 2024-01-16 | 2024-01-18 | 15,400 | — | $0 | 15,400 | SEC↗ |
| Noonberg Sarah B. | Director | A Award deriv | 2024-01-16 | 2024-01-18 | 15,400 | — | $0 | 15,400 | SEC↗ |
| PALEKAR ROHAN | Director | A Award deriv | 2024-01-16 | 2024-01-18 | 15,400 | — | $0 | 15,400 | SEC↗ |
| Woods Robert Keith | Director | A Award deriv | 2024-01-16 | 2024-01-18 | 15,400 | — | $0 | 15,400 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director | A Award deriv | 2023-12-18 | 2023-12-20 | 310,130 | — | $0 | 1,283,420 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director | A Award deriv | 2023-12-18 | 2023-12-20 | 93,480 | — | $0 | 221,149 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director | A Award deriv | 2023-12-18 | 2023-12-20 | 221,557 | — | $0 | 1,504,977 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director | A Award deriv | 2023-12-18 | 2023-12-20 | 20,562 | — | $0 | 127,669 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director | A Award deriv | 2023-12-18 | 2023-12-20 | 1,151,124 | — | $0 | 2,656,101 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director | A Award deriv | 2023-12-18 | 2023-12-20 | 28,782 | — | $0 | 107,107 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director | A Award deriv | 2023-12-18 | 2023-12-20 | 78,325 | — | $0 | 78,325 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director | A Award deriv | 2023-12-18 | 2023-12-20 | 973,290 | — | $0 | 973,290 | SEC↗ |